.
.
.
.
Coronavirus

US authorizes Pfizer/BioNTech COVID-19 vaccine for children as young as 12

Published: Updated:

US regulators on Monday authorized Pfizer and BioNTech’s COVID-19 vaccine for use in children as young as 12, widening the country’s inoculation program as vaccination rates have slowed significantly.

Read the latest updates in our dedicated coronavirus section.

The vaccine has been available under an emergency use authorization to people as young as 16 in the US. The vaccine makers said they had started the process for full approval for those ages last week.

The US Food and Drug Administration said it was amending the EUA to include the millions of children aged 12 to 15.

Read more:

India doctors warn of deadly rare fungal infection in COVID-19 patients

Far-right using COVID-19 conspiracy theories to lure young supporters: UK police

Kuwait suspends travel from Pakistan, Bangladesh, Nepal, Sri Lanka to contain COVID